Fratellone PM, Holowecki MA. Forgotten node: A case report. World J Gastroenterol 2009; 15(39): 4974-4975 [PMID: 19842232 DOI: 10.3748/wjg.15.4974]
Corresponding Author of This Article
Patrick M Fratellone, MD, Fratellone Medical Associates, 47 West 57th Street 5th Floor New York, NY 10019, United States. email@example.com
Article-Type of This Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Oct 21, 2009; 15(39): 4974-4975 Published online Oct 21, 2009. doi: 10.3748/wjg.15.4974
Forgotten node: A case report
Patrick M Fratellone, Melissa A Holowecki
Patrick M Fratellone, Melissa A Holowecki, Fratellone Medical Associates, 47 West 57th Street 5th Floor New York, NY 10019, United States
Author contributions: Fratellone PM and Holowecki MA contributed equally to this work; Fratellone PM wrote the paper.
Correspondence to: Patrick M Fratellone, MD, Fratellone Medical Associates, 47 West 57th Street 5th Floor New York, NY 10019, United States. firstname.lastname@example.org
Telephone: +1-212-4213202 Fax: +1-212-4217207
Received: May 13, 2009 Revised: August 24, 2009 Accepted: August 31, 2009 Published online: October 21, 2009
Sister Mary Joseph nodule or node refers to a palpable nodule bulging into the umbilicus and is usually a result of a malignant cancer in the pelvis or abdomen. Traditionally it has been considered a sign of ominous prognosis. Gastrointestinal malignancies, most commonly gastric, colon and pancreatic cancer account for about 52% of the underlying sources. Gynecological cancers, most commonly ovarian and uterine cancers account for about 28% of the sources.